CCN2 and cancer: Several studies have revealed that the activation of the JAK-STAT pathway by cytokines has been shown to regulate fibrogenic cytokines such as transforming growth factor-β1 and connective tissue growth factor [74], as well as enhancing liver fibrosis and cancer [75–77].